OPPORTUNITIES FOR HIGH-COST DRUGS IN INDIA

被引:0
|
作者
Ramabadran, A. [1 ]
Samuel, J. J. [2 ]
Edathodu, A. [2 ]
Mukku, S. R. [2 ]
机构
[1] Univ Cambridge, Cambridge, England
[2] Access Infin Ltd, London, England
关键词
D O I
暂无
中图分类号
F [经济];
学科分类号
02 ;
摘要
PCN240
引用
收藏
页码:A131 / A131
页数:1
相关论文
共 50 条
  • [1] Patents Associated with High-Cost Drugs in Australia
    Christie, Andrew F.
    Dent, Chris
    McIntyre, Peter
    Wilson, Lachlan
    Studdert, David M.
    PLOS ONE, 2013, 8 (04):
  • [2] Evolution of consumption of high-cost drugs in Colombia
    Machado Alba, Jorge Enrique
    Moncada Escobar, Juan Carlos
    REVISTA PANAMERICANA DE SALUD PUBLICA-PAN AMERICAN JOURNAL OF PUBLIC HEALTH, 2012, 31 (04): : 283 - 289
  • [3] CLINICAL AND ETHICAL PERSPECTIVES ON RATIONING OF HIGH-COST DRUGS
    POIRIER, TI
    GIANNETTI, VJ
    ANNALS OF PHARMACOTHERAPY, 1995, 29 (01) : 78 - 81
  • [4] High-Cost Generic Drugs - Implications for Patients and Policymakers
    Uhl, Kathleen
    Peters, John R.
    Flanagan, Keith
    NEW ENGLAND JOURNAL OF MEDICINE, 2015, 372 (07): : 685 - 686
  • [5] High-Cost Generic Drugs - Implications for Patients and Policymakers
    Alpern, Jonathan D.
    Stauffer, William M.
    Kesselheim, Aaron S.
    NEW ENGLAND JOURNAL OF MEDICINE, 2014, 371 (20): : 1859 - 1862
  • [6] High-Cost Generic Drugs - Implications for Patients and Policymakers Reply
    Kesselheim, Aaron S.
    Alpern, Jonathan D.
    Stauffer, William M.
    NEW ENGLAND JOURNAL OF MEDICINE, 2015, 372 (07): : 686 - 686
  • [7] HIGH-COST ERRORS
    SIRBU, SE
    DATAMATION, 1989, 35 (08): : 6 - 6
  • [8] HIGH-COST CAPITAL
    不详
    ECONOMIC AND POLITICAL WEEKLY, 1995, 30 (39) : 2403 - 2404
  • [9] Novelty of Active Ingredients in High-Cost Brand-Name Drugs
    Emily H. Jung
    Ameet Sarpatwari
    Aaron S. Kesselheim
    Journal of General Internal Medicine, 2020, 35 : 2219 - 2221
  • [10] Novelty of Active Ingredients in High-Cost Brand-Name Drugs
    Jung, Emily H.
    Sarpatwari, Ameet
    Kesselheim, Aaron S.
    JOURNAL OF GENERAL INTERNAL MEDICINE, 2020, 35 (07) : 2219 - 2221